Cargando…

Development and validation of an individualized immune prognostic model in stage I–III lung squamous cell carcinoma

Lung squamous cell carcinoma (LUSC) possesses a poor prognosis even for stages I–III resected patients. Reliable prognostic biomarkers that can stratify and predict clinical outcomes for stage I–III resected LUSC patients are urgently needed. Based on gene expression of LUSC tissue samples from five...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Qi-Fan, Wu, Di, Wang, Jian, Ba, Li, Tian, Chen, Liu, Yu-Ting, Hu, Yue, Liu, Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8209222/ https://www.ncbi.nlm.nih.gov/pubmed/34135424 http://dx.doi.org/10.1038/s41598-021-92115-0

Ejemplares similares

Prognostic evaluation of esophageal cancer patients with stages I-III
por: Qiu, Meng-jun, et al.
Publicado: (2020)

Development and validation of prognostic nomograms based on De Ritis ratio and clinicopathological features for patients with stage II/III colorectal cancer
por: Fu, Jinming, et al.
Publicado: (2023)

Prognostic significance of preoperative prognostic immune and nutritional index in patients with stage I–III colorectal cancer
por: Xie, Hailun, et al.
Publicado: (2022)

Development of a Prognostic Nomogram for Patients with Lung Adenocarcinoma in the Stages I, II, and III Based on Immune Scores
por: Xie, Hui, et al.
Publicado: (2021)

Development and validation of a prognostic index for efficacy evaluation and prognosis of first-line chemotherapy in stage III–IV lung squamous cell carcinoma
por: Song, Jiangdian, et al.
Publicado: (2019)

Preoperative lymphocyte-monocyte ratio is not an independent prognostic factor in M0 (stage I–III) esophageal squamous cell carcinomas
por: Chen, Chao, et al.
Publicado: (2020)

The prognostic value of CXC subfamily ligands in stage I-III patients with colorectal cancer
por: Li, Xiangde, et al.
Publicado: (2019)

Serum miRNA expression profile as a prognostic biomarker of stage II/III colorectal adenocarcinoma
por: Li, Jialu, et al.
Publicado: (2015)

The development and validation of a CT-based radiomics signature for the preoperative discrimination of stage I-II and stage III-IV colorectal cancer
por: Liang, Cuishan, et al.
Publicado: (2016)

Prognostic value of a modified Immunoscore in patients with stage I−III resectable colon cancer
por: Zhao, Ke, et al.
Publicado: (2021)

Construction and validation of a survival prognostic model for stage III hepatocellular carcinoma: a real-world, multicenter clinical study
por: Hao, Shuai, et al.
Publicado: (2023)

Prognostic and predictive value of radiomics signatures in stage I‐III colon cancer
por: Dai, Weixing, et al.
Publicado: (2020)

Patterns of care and prognostic evaluation for stage I–III upper esophageal squamous cell carcinoma: a population-based study
por: Chen, Dongbo, et al.
Publicado: (2022)

Identification and validation of an individualized prognostic signature of lung squamous cell carcinoma based on ferroptosis‐related genes
por: Diao, Xiayao, et al.
Publicado: (2021)

Construction and Validation of Convenient Clinicopathologic Signatures for Predicting the Prognosis of Stage I-III Gastric Cancer
por: You, Weiqiang, et al.
Publicado: (2022)

Evaluation of Traditional Prognostic Factors for Stage I-III Colorectal Cancer Patients Who Survived for Over Five Years After Surgery
por: Luo, Dakui, et al.
Publicado: (2021)

Identification of an Individualized Immune-Related Prognostic Risk Score in Lung Squamous Cell Cancer
por: Zhuang, Yuan, et al.
Publicado: (2021)

Chemoradiation with capecitabine and mitomycin-C for stage I-III anal squamous cell carcinoma
por: Thind, Govin, et al.
Publicado: (2014)

A prognostic nomogram for predicting recurrence-free survival of stage I–III colon cancer based on immune-infiltrating Treg-related genes
por: Xu, Longwen, et al.
Publicado: (2023)

Prognostic Value of Radiotherapy and Chemotherapy in Stage I–III Merkel Cell Carcinoma
por: Bi, Aihong, et al.
Publicado: (2022)

Development and validation of a novel miRNA classifier as a prognostic signature for stage II/III colorectal cancer
por: Feng, Junlan, et al.
Publicado: (2021)

Prognostic value of the lymph node ratio in stage III colorectal cancer
por: Ren, Jing-Qing, et al.
Publicado: (2012)

Identification of Prognostic Model Based on Immune-Related LncRNAs in Stage I-III Non-Small Cell Lung Cancer
por: Li, Qiaxuan, et al.
Publicado: (2021)

Cohort size required for prognostic genes analysis of stage II/III esophageal squamous cell carcinoma
por: Kong, Linghong, et al.
Publicado: (2023)

Development and validation of a novel immune-related prognostic model in lung squamous cell carcinoma
por: Liu, Zeyu, et al.
Publicado: (2020)

Development and Validation of a Nomogram for Predicting the Risk of Bell's Stage II/III Necrotizing Enterocolitis in Neonates Compared to Bell's Stage I
por: Song, Shuting, et al.
Publicado: (2022)

Nuclear TEAD4 with SIX1 Overexpression is an Independent Prognostic Marker in the Stage I–III Colorectal Cancer
por: Yu, Tong, et al.
Publicado: (2021)

Applying post-neoadjuvant pathologic stage as prognostic tool in esophageal squamous cell carcinoma
por: Han, Weiming, et al.
Publicado: (2022)

Hallmark guided identification and characterization of a novel immune-relevant signature for prognostication of recurrence in stage I–III lung adenocarcinoma
por: Zhang, Yongqiang, et al.
Publicado: (2022)

Implications of Habitual Alcohol Intake With the Prognostic Significance of Mean Corpuscular Volume in Stage II-III Colorectal Cancer
por: Liu, Qi, et al.
Publicado: (2021)

Prognostic Impact of PD-1 and Tim-3 Expression in Tumor Tissue in Stage I-III Colorectal Cancer
por: Kuai, Wentao, et al.
Publicado: (2020)

Exploration and validation of radiomics signature as an independent prognostic biomarker in stage III-IVb nasopharyngeal carcinoma
por: Ouyang, Fu-Sheng, et al.
Publicado: (2017)

Prognostic Evaluation of Metastasis-Related Lymphocyte/Monocyte Ratio in Stage Ⅰ-Ⅲ Breast Cancer Receiving Chemotherapy
por: Zhang, Zihan, et al.
Publicado: (2022)

Necrosis score as a prognostic factor in stage I–III colorectal cancer: a retrospective multicenter study
por: Ye, Huifen, et al.
Publicado: (2023)

Identification of an Innate Immune-Related Prognostic Signature in Early-Stage Lung Squamous Cell Carcinoma
por: Li, Liang, et al.
Publicado: (2021)

Concurrent validity of the Ages and Stages Questionnaire and the Bayley Scales of Infant Development III in China
por: Yue, Ai, et al.
Publicado: (2019)

Decreased expression of eukaryotic initiation factor 3f is an adverse prognostic factor for stage I–III gastric cancer
por: Li, Guanghua, et al.
Publicado: (2014)

Prognostic significance of tumor genotypes and CD8+ infiltrates in stage I-III colorectal cancer
por: Fountzilas, Elena, et al.
Publicado: (2018)

Prognostic impact of CD34 and SMA in cancer‐associated fibroblasts in stage I–III NSCLC
por: Schulze, Arik Bernard, et al.
Publicado: (2019)

Prognostic Potential of the Baseline Pan-Immune-Inflammation Value and Neutrophil/Lymphocyte Ratio in Stage I to III Melanoma Patients
por: Gambichler, Thilo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rgnm6qf1jl1ejr4andmqu7itd1